INDUSTRY BUZZ

Arizona Fraud Suit Opens New Front in the Legal War against Theranos

The Arizona Attorney General's Office (AGO) recently issued a request for proposal signaling a new legal battle for Theranos: state consumer fraud lawsuits. The AGO indicated in its request that it … [Read more...]

REIMBURSEMENT

Update on Palmetto’s Molecular Dx Testing LCDs

Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for payors as far as coverage is concerned. Normally … [Read more...]

LCDs

Palmetto Latest Medicare Contractor to Loosen Up on Covering Molecular Dx Testing

Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for payors as far as coverage is concerned. Normally … [Read more...]

PRECISION MEDICINE

Quest Diagnostics Unveils a Pair of Personalized Medicine Blockbusters

Public support for personalized and precision medicine (PM) is running ahead of the health care industry's plans to develop and implement PM-based clinical strategies. At least that is the … [Read more...]

REIMBURSEMENT

OIG Report: Total Medicare Lab Test Payments in 2015 Same as in 2014

Medicare Part B paid $7 billion for lab tests in 2015, the same amount it shelled out in 2014. But 2015 Medicare payments for the top 25 lab tests dipped slightly to $4.1 billion, as compared to $4.2 … [Read more...]

EARNINGS

Publicly-Traded Esoteric Labs Are Off to Good Start in 2016

As personalized medicine continues to gain traction in the United States, the publicly-traded esoteric laboratories continue to chug along, posting strong growth numbers, even as some have yet to … [Read more...]

EARNINGS

Publicly-Traded Esoteric Laboratories Posted Big Revenue Gains for First Half of 2016

As personalized medicine continues to gain traction in the United States, the publicly-traded esoteric laboratories continue to chug along, with most reporting significantly higher revenue for the … [Read more...]

REIMBURSEMENT

Despite Changes in Final PAMA Rule, Many Hospital Labs May Still Not Be Reporting

When the Centers for Medicare & Medicaid Services announced in mid- June the final rules governing the Protecting the Access to Medicare Act (PAMA), it drew praise from several groups that had … [Read more...]

REIMBURSEMENT

Pathology, Lab Communities Weigh In on Proposed MACRA Rules

Last year the long-maligned Sustainable Growth Rate payment formula was replaced with the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), a system where providers are paid in part based … [Read more...]

REIMBURSEMENT

CMS’s Proposed Gapfill Prices for Molecular Tests Would Lead to Big Reimbursement Cuts

The Centers for Medicare & Medicaid Services (CMS) published interim gapfill prices last month for new CPT codes for molecular tests introduced earlier this year. Although the pricing was for a … [Read more...]


(-0000g2)